Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Inukai

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cureus|April 4, 2025
Decline of Persistent Jaundice in a Patient With Autoimmune Hepatitis and Vanishing Bile Duct Syndrome Treated With Elobixibat for ConstipationTân Trần Thị, Norihiro Imai, Yosuke Inukai, et al.
Radiology Case Reports|September 10, 2025
Successful embolization of a large intrahepatic portosystemic shunt using the coil-in-plug technique: A case report assessed with four-dimensional flow magnetic resonance imagingRyota Horiguchi, Ryota Hyodo, Daiki Tamashiro, et al.
Clinical Journal of Gastroenterology|February 10, 2017
Discrepant imaging findings of portal vein thrombosis with dynamic computed tomography and computed tomography during arterial portography in hepatocellular carcinoma: possible cause leading to inappropriate treatment selectionHidenori Toyoda, Takashi Kumada, Toshifumi Tada, et al.
Digestive Diseases (Basel, Switzerland)|March 28, 2022
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular CarcinomaYosuke Inukai, Kenta Yamamoto, Takashi Honda, et al.
Microorganisms|March 28, 2024
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver DiseaseKenta Yamamoto, Takashi Honda, Yosuke Inukai, et al.
Cancers|May 11, 2024
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular CarcinomaYosuke Inukai, Kenta Yamamoto, Takashi Honda, et al.
Anticancer Research|July 27, 2022
Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular CarcinomaNorihiro Imai, Masatoshi Ishigami, Yumi Oie, et al.
Annals of Hepatology|September 27, 2021
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaYosuke Inukai, Norihiro Imai, Kenta Yamamoto, et al.
Journal of Digestive Diseases|January 13, 2025
Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver DiseaseYosuke Inukai, Takanori Ito, Shinya Yokoyama, et al.
Hepatology International|January 27, 2025
Gut microbes associated with functional cure of chronic hepatitis BTakashi Honda, Masatoshi Ishigami, Yoji Ishizu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cureus|April 4, 2025
Decline of Persistent Jaundice in a Patient With Autoimmune Hepatitis and Vanishing Bile Duct Syndrome Treated With Elobixibat for ConstipationTân Trần Thị, Norihiro Imai, Yosuke Inukai, et al.
Radiology Case Reports|September 10, 2025
Successful embolization of a large intrahepatic portosystemic shunt using the coil-in-plug technique: A case report assessed with four-dimensional flow magnetic resonance imagingRyota Horiguchi, Ryota Hyodo, Daiki Tamashiro, et al.
Clinical Journal of Gastroenterology|February 10, 2017
Discrepant imaging findings of portal vein thrombosis with dynamic computed tomography and computed tomography during arterial portography in hepatocellular carcinoma: possible cause leading to inappropriate treatment selectionHidenori Toyoda, Takashi Kumada, Toshifumi Tada, et al.
Digestive Diseases (Basel, Switzerland)|March 28, 2022
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular CarcinomaYosuke Inukai, Kenta Yamamoto, Takashi Honda, et al.
Microorganisms|March 28, 2024
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver DiseaseKenta Yamamoto, Takashi Honda, Yosuke Inukai, et al.
Cancers|May 11, 2024
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular CarcinomaYosuke Inukai, Kenta Yamamoto, Takashi Honda, et al.
Anticancer Research|July 27, 2022
Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular CarcinomaNorihiro Imai, Masatoshi Ishigami, Yumi Oie, et al.
Annals of Hepatology|September 27, 2021
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaYosuke Inukai, Norihiro Imai, Kenta Yamamoto, et al.
Journal of Digestive Diseases|January 13, 2025
Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver DiseaseYosuke Inukai, Takanori Ito, Shinya Yokoyama, et al.
Hepatology International|January 27, 2025
Gut microbes associated with functional cure of chronic hepatitis BTakashi Honda, Masatoshi Ishigami, Yoji Ishizu, et al.
Pageof 2